Recombinant human erythropoietin plus methylprednisolone versus methylprednisolone in treatment of acute spinal cord injury：protocol for a systematic review and meta-analysis

INTRODUCTION: Recent studies in animal models indicate that recombinant human erythropoietin (rHuEPO) is very effective in enhancing neurological recovery after spinal cord injury (SCI). We described a protocol aimed at evaluating the efficacy of rHuEPO plus methylprednisolone (MP) compared with MP...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Miao, Zhou, Jiaojiao, Huang, Shishu, Zhang, Yonggang, He, Yu, Zeng, Yong, Song, Yueming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Evidence Based Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730378/
https://www.ncbi.nlm.nih.gov/pubmed/36600375
http://dx.doi.org/10.1136/bmjopen-2021-056689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730378/
https://www.ncbi.nlm.nih.gov/pubmed/36600375
http://dx.doi.org/10.1136/bmjopen-2021-056689

Ejemplares similares